Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.66M Buy
18,395
+1,012
+6% +$346K 0.25% 63
2026
Q1
$6.12M Buy
17,383
+1,344
+8% +$479K 0.29% 52
2025
Q4
$5.25M Buy
16,039
+2,901
+22% +$920K 0.26% 58
2025
Q3
$3.71M Buy
13,138
+1,365
+12% +$396K 0.2% 67
2025
Q2
$3.29M Buy
11,773
+20
+0.2% +$5.67K 0.21% 72
2025
Q1
$3.66M Buy
11,753
+3,369
+40% +$995K 0.27% 63
2024
Q4
$2.19M Sell
8,384
-2,036
-20% -$604K 0.19% 93
2024
Q3
$3.36M Buy
10,420
+2,130
+26% +$697K 0.33% 41
2024
Q2
$2.59M Buy
8,290
+4,338
+110% +$1.27M 0.35% 39
2024
Q1
$1.12M Buy
3,952
+36
+0.9% +$10.5K 0.23% 70
2023
Q4
$1.23M Buy
+3,916
New +$1.07M 0.33% 45

Other funds holding AMGN

GAMMA Investing's AMGN Position: Q2 2026 in Review

GAMMA Investing increased its Amgen (AMGN) stake by 5.8% in Q2 2026, buying an estimated $346K and bringing the position to 18,395 shares worth $6.66M. The position accounts for 0.25% of the portfolio, ranked #63.

GAMMA Investing first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 990 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • GAMMA Investing held 18,395 shares of Amgen worth $6.66M as of Q2 2026.
  • GAMMA Investing bought 1,012 Amgen shares in Q2 2026, an estimated $346K.
  • Amgen made up 0.25% of GAMMA Investing's portfolio in Q2 2026, its #63 holding.
  • GAMMA Investing first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 990 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.